Monthly information related to total number of voting rights and shares composing the share capital – October 8, 2024
PHAXIAM Therapeutics has released its monthly update on voting rights and share capital as of October 8, 2024. The company's total number of shares composing the share capital stands at 10,013,719. The total number of gross (theoretical) voting rights is 10,165,848, while the total number of net voting rights (excluding treasury shares) is 10,165,599.
The report provides a historical breakdown of these figures from December 31, 2023, to October 8, 2024. Notably, there was a significant increase in the number of shares and voting rights between May 31, 2024, and July 1, 2024. The company's shares are listed on Euronext Paris (Market segment C) under the symbol PHXM with ISIN Code FR001400K4B1.
PHAXIAM Therapeutics ha rilasciato il suo aggiornamento mensile sui diritti di voto e sul capitale sociale al 8 ottobre 2024. Il numero totale di azioni costituenti il capitale sociale è di 10.013.719. Il numero totale di diritti di voto lordi (teorici) è 10.165.848, mentre il numero totale di diritti di voto netti (escludendo le azioni proprie) è 10.165.599.
Il rapporto fornisce una ripartizione storica di queste cifre dal 31 dicembre 2023 all'8 ottobre 2024. È importante notare che c'è stata un'incremento significativo nel numero di azioni e diritti di voto tra il 31 maggio 2024 e il 1 luglio 2024. Le azioni della società sono quotate su Euronext Paris (segmento di mercato C) con il simbolo PHXM e con il codice ISIN FR001400K4B1.
PHAXIAM Therapeutics ha lanzado su actualización mensual sobre derechos de voto y capital social a partir del 8 de octubre de 2024. El número total de acciones que componen el capital social es de 10.013.719. El número total de derechos de voto brutos (teóricos) es 10.165.848, mientras que el número total de derechos de voto netos (excluyendo las acciones propias) es 10.165.599.
El informe proporciona un desglose histórico de estas cifras desde el 31 de diciembre de 2023 hasta el 8 de octubre de 2024. Cabe destacar que hubo un aumento significativo en el número de acciones y derechos de voto entre el 31 de mayo de 2024 y el 1 de julio de 2024. Las acciones de la compañía están listadas en Euronext Paris (segmento de mercado C) bajo el símbolo PHXM con el código ISIN FR001400K4B1.
PHAXIAM Therapeutics는 2024년 10월 8일 기준의 의결권 및 자본금에 대한 월간 업데이트를 발표했습니다. 회사의 총 주식 수는 10,013,719주입니다. 총 의결권(이론적)은 10,165,848개이며, 자Treasury 주식을 제외한 총 순 의결권은 10,165,599개입니다.
이 보고서는 2023년 12월 31일부터 2024년 10월 8일까지의 이러한 수치에 대한 역사적 분석을 제공합니다. 특히 2024년 5월 31일부터 7월 1일 사이에 주식과 의결권의 수가 크게 증가했습니다. 이 회사의 주식은 Euronext Paris (시장 부문 C)에서 기호 PHXM으로 상장되어 있으며, ISIN 코드 FR001400K4B1로 등록되어 있습니다.
PHAXIAM Therapeutics a publié sa mise à jour mensuelle sur les droits de vote et le capital social en date du 8 octobre 2024. Le nombre total d'actions composant le capital social s'élève à 10.013.719. Le nombre total de droits de vote bruts (théoriques) est de 10.165.848, tandis que le nombre total de droits de vote nets (hors actions propres) est de 10.165.599.
Le rapport présente une répartition historique de ces chiffres du 31 décembre 2023 au 8 octobre 2024. Il convient de noter qu'il y a eu une augmentation significative du nombre d'actions et de droits de vote entre le 31 mai 2024 et le 1er juillet 2024. Les actions de la société sont cotées sur Euronext Paris (segment de marché C) sous le symbole PHXM avec le code ISIN FR001400K4B1.
PHAXIAM Therapeutics hat sein monatliches Update zu Stimmrechten und Eigenkapital zum 8. Oktober 2024 veröffentlicht. Die Gesamtzahl der Aktien, die das Eigenkapital ausmachen, beträgt 10.013.719. Die Gesamtzahl der Bruttostimmrechte (theoretisch) beträgt 10.165.848, während die Gesamtzahl der Nettostimmrechte (ohne eigene Aktien) 10.165.599 beträgt.
Der Bericht liefert eine historische Aufschlüsselung dieser Zahlen vom 31. Dezember 2023 bis zum 8. Oktober 2024. Besonders hervorzuheben ist der signifikante Anstieg der Aktien und Stimmrechte zwischen dem 31. Mai 2024 und dem 1. Juli 2024. Die Aktien des Unternehmens sind an der Euronext Paris (Marktsegment C) unter dem Symbol PHXM mit der ISIN-Nummer FR001400K4B1 gelistet.
- Increase in total number of shares from 6,075,105 to 10,013,719 between May and October 2024
- Growth in gross voting rights from 6,226,989 to 10,165,848 in the same period
- Expansion of net voting rights from 6,226,740 to 10,165,599
- None.
Listing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM)
Website : www.phaxiam.com
| Date | Total of shares composing the share capital | Total of brut (1) voting rights | Total of net (2) voting rights |
| December 31, 2023 | 6 075 105 | 6 226 982 | 6 226 733 |
| January 31, 2024 | 6 075 105 | 6 227 002 | 6 226 753 |
| February 29, 2024 | 6 075 105 | 6 226 951 | 6 226 702 |
| March 29, 2024 | 6 075 105 | 6 226 938 | 6 226 689 |
| April 30, 2024 | 6 075 105 | 6 226 932 | 6 226 683 |
| May 31, 2024 | 6 075 105 | 6 226 989 | 6 226 740 |
| July 1, 2024 | 9 980 668 | 10 132 597 | 10 132 348 |
| October 8, 2024 | 10 013 719 | 10 165 848 | 10 165 599 |
(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares.
Attachment
FAQ
What is the current number of shares in PHXM's share capital as of October 8, 2024?
How many gross voting rights does PHXM have as of October 8, 2024?
What is the difference between PHXM's gross and net voting rights?
When did PHXM experience a significant increase in its share capital in 2024?
